First Trust NASDAQ Cybersecurity ETF vs 10X Genomics Inc — how do they compare? First Trust NASDAQ Cybersecurity ETF trades at $95.05, while 10X Genomics Inc trades at $45.99 (market cap $5.30B). Which is the better fit depends on your goals.
| CIBR | TXG | |
|---|---|---|
52-Week High | $94.73 | $45.80 |
52-Week Low | $60.74 | $11.34 |
Market Cap | — | $5.30B |
Sector | — | Health |
Enterprise Value | — | $4.85B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TXG trades at $41.77, down 2.25% today, with a bullish technical setup supported by moving averages. The company shows improving fundamentals with revenue growth to $642.82M in 2025 and narrowing losses, while recent collaborations with Cleveland Clinic and the Proteintech acquisition expand its diagnostic capabilities. Analyst sentiment is mixed with 45% buy ratings but a consensus price target below current levels.
The outlook suggests cautious optimism as TXG demonstrates operational improvement with positive cash flow generation, though profitability remains elusive. Key risks include execution challenges in new ventures and competitive pressures, while upside potential hinges on continued margin expansion and successful integration of recent acquisitions.
Trailing returns across standard periods
Latest headlines on both assets
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →